Transthyretin Amyloid Cardiomyopathy (ATTR-CM)
May 29, 2024 · Transthyretin amyloid cardiomyopathy (ATTR-CM) is an underdiagnosed and potentially fatal disease of the heart muscle. As it progresses, the heart can become unable to adequately …
ATTR-CM Discovery | American Heart Association
ATTR-CM Discovery Initiative THE ISSUE Cardiac amyloidosis, including Transthyretin Amyloid Cardiomyopathy (ATTR-CM), is a serious and often underdiagnosed condition in which protein …
Transthyretin Amyloidosis (ATTR) for Professionals
Video webinar series helps instructs healthcare professionals in improving care and treatment for patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM).
Nationwide effort targets diagnosis delays, care gaps for a life ...
Mar 23, 2026 · Early recognition and diagnosis of ATTR-CM is critical, as timely care gives patients access to treatments that can extend survival, preserve physical function and maintain quality of life. …
Genetic Testing and Counseling for Hereditary Transthyretin …
May 31, 2024 · Learn about the importance of genetic testing for hATTR Amyloidosis, including who should get tested and genetic counseling.
To join a gene editing trial, a person usually needs to meet certain requirements, such as: 1 Having a confirmed diagnosis of a genetic condition that affects the heart, like ATTR-CM 2 Having specific …
Guidelines in a New Era for Cardiac Amyloidosis
Nov 22, 2024 · For instance, low QRS voltage on ECG is a late finding in cardiac amyloidosis present in fewer than half of people with biopsy-proven ATTR-CM, in contrast with earlier studies …
Advancing access to clinical trials for cardiomyopathy
May 27, 2025 · As part of this work, the Association today announced an initiative to improve education, outreach and access to clinical trials for gene editing therapies for transthyretin amyloid …
ATTR-CM: Severity & Relevance to Practice Diagnostic delays are common and diagnosis in ATTR-CM and diagnosis is often made at a more advanced stage
Cardiac Amyloidosis: Evolving Diagnosis and Management
Jun 1, 2020 · ATTR-CM is a restrictive cardiomyopathy that results from the extracellular myocardial deposition of amyloid fibrils composed of the protein transthyretin (TTR). Readily accessible, …